Pediatrics

In the wake of a resurgence of measles cases and deaths globally, experts are worried about the decline in vaccinations during the pandemic.

Often what parents reach for to relieve a child’s pain or fever, a new meta-analysis looks at the efficacy and safety of ibuprofen and acetaminophen.

MJH Life Sciences™ COVID-19 Coalition will be hosting its next live webinar event “Thinking Long-Term: COVID-19’s Clinical Consequences and Mental Health Effects."

The FDA approved the treatment through the prescription-to-OTC switch process.

The program is designed to prepare state-licensed pharmacists to meet requirements for administering vaccinations to pediatric patients.

A poster at the virtual 2020 ID Week looked at how vaccine type can impact diphtheria, tetanus, and acellular pertussis (DTaP) vaccination.

Controlling exposure to antibiotics is important for stewardship programs, and even more so in neonatal intensive care units.

The new guidance provides clarification on requirements for pharmacy interns and technicians to administer childhood and COVID-vaccines, as well as COVID-19 tests.

Results of a phase 3 trial showed clinical benefits with dupilumab (Dupixent; Sanofi and Regeneron) in children with uncontrolled moderate-to-severe asthma.

An investigation examines whether an intervention including both school and home components improves asthma outcomes.

Tofacitinib (Xeljanz; Pfizer) is the first and only Janus kinase inhibitor approved in the US for this indication.

A recent report looked at whether human papilloma virus (HPV) vaccination coverage will meet the Healthy People 2020 goal.

The American Academy of Pediatrics (AAP) has issued its recommendations for the 2020-2021 influenza season.

The MiniMed 770G system (Medtronic) is approved for use by individuals aged 2 to 6 with type 1 diabetes.

NACDS is urging states to provide clarity on pharmacist-provided childhood vaccinations, and enhance overall patient access to vaccines.

Twelve pharmacy organization issued a joint statement in response to the expansion of the pharmacist's role in providing vaccines to children.

Caregivers of children with ADHD can choose from an increasing number of treatments that can be customized.

Officials with the FDA approved fenfluramine (Fintepla, Zogenix) oral solution, CIV for the treatment of seizures associated with Dravet syndrome in patients 2 years of age and older.

The FDA warned that the dosing cups, which were missing some graduation markings, could cause an accidental overdose.

The phase 2/3 trials will evaluate remdesivir (Gilead) in pediatric patients, from newborns to adolescents, who have contracted severe COVID-19 symptoms.

EndeavorRx (Akili Interactive), a prescription-only game-based device, is indicated for use in children ages 8 to 12 years old with primarily inattentive or combined-type ADHD who have demonstrated an attention issue.

The study warned that, with 74 million children in the United States, PICU resources could face concerning strain from COVID-19.

The study estimates that for each child in the PICU for COVID-19, another 2381 children are infected with the virus.

Pediatricians stress the importance of understanding the effects of COVID-19 on children.

The FDA previously approved sofosbuvir and velpatasvir to treat HCV in adults.